Very dilute concentrations appear lighter blue, which is normal
However, if it is almost time for your next dose, skip the missed dose and take the next scheduled dose in the prescribed time
The use of MOTs-C as a companion to GLP-1s, to prevent muscle loss, might get around this shortcoming of GLP-1s, but rigorous research is needed to prove [its effectiveness]
Related Articles & Guides articles Compounded GLP-1s: FDA Docket Closed, 3,901 Comments The FDA's plan to bar 503B bulk compounding of semaglutide, tirzepatide and liraglutide drew 3,901 comments before the July 30 cutoff
These findings suggest a potential beneficial effect of semaglutide on glycemic status, but whether semaglutide treatment delays or prevents progression to type 2 diabetes requires confirmation